ArticleJournal of molecular medicine (Berlin, Germany)2008

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.

Martin A Storr et al.PubMed ↗Publisher ↗

No numbers read from the abstract.